vs
Amneal Pharmaceuticals, Inc.（AMRX）与Ubiquiti Inc.（UI）财务数据对比。点击上方公司名可切换其他公司
Ubiquiti Inc.的季度营收约是Amneal Pharmaceuticals, Inc.的1.1倍（$814.9M vs $722.5M），Ubiquiti Inc.净利率更高（28.7% vs 10.8%，领先17.9%），Ubiquiti Inc.同比增速更快（35.8% vs 3.9%），过去两年Ubiquiti Inc.的营收复合增速更高（28.6% vs 1.5%）
Amneal Pharmaceuticals是一家美国上市制药企业，核心业务涵盖仿制药及专科药物的研发、生产与分销，总部位于新泽西州布里奇沃特，是美国规模最大的仿制药生产商之一。
Ubiquiti Inc.是一家美国科技企业，2003年于加利福尼亚州圣何塞成立，目前总部位于纽约。公司旗下拥有多个品牌，主营面向企业及家庭用户的有线、无线数据通信产品的研发、生产与销售。
AMRX vs UI — 直观对比
营收规模更大
UI
是对方的1.1倍
$722.5M
营收增速更快
UI
高出31.9%
3.9%
净利率更高
UI
高出17.9%
10.8%
两年增速更快
UI
近两年复合增速
1.5%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $722.5M | $814.9M |
| 净利润 | $78.0M | $233.6M |
| 毛利率 | 44.3% | 45.9% |
| 营业利润率 | 19.6% | 35.9% |
| 净利率 | 10.8% | 28.7% |
| 营收同比 | 3.9% | 35.8% |
| 净利润同比 | 410.5% | 70.8% |
| 每股收益（稀释后） | $0.19 | $3.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRXUI
| Q1 26 | $722.5M | — | ||
| Q4 25 | $814.3M | $814.9M | ||
| Q3 25 | $784.5M | $733.8M | ||
| Q2 25 | $724.5M | $759.2M | ||
| Q1 25 | $695.4M | $664.2M | ||
| Q4 24 | $730.5M | $599.9M | ||
| Q3 24 | $702.5M | $550.3M | ||
| Q2 24 | $701.8M | $507.5M |
净利润AMRXUI
| Q1 26 | $78.0M | — | ||
| Q4 25 | $35.1M | $233.6M | ||
| Q3 25 | $2.4M | $207.9M | ||
| Q2 25 | $22.4M | $266.7M | ||
| Q1 25 | $12.2M | $180.4M | ||
| Q4 24 | $-31.1M | $136.8M | ||
| Q3 24 | $-156.0K | $128.0M | ||
| Q2 24 | $6.0M | $103.8M |
毛利率AMRXUI
| Q1 26 | 44.3% | — | ||
| Q4 25 | 36.5% | 45.9% | ||
| Q3 25 | 34.9% | 46.0% | ||
| Q2 25 | 39.5% | 45.1% | ||
| Q1 25 | 36.8% | 44.5% | ||
| Q4 24 | 36.0% | 41.2% | ||
| Q3 24 | 38.4% | 42.1% | ||
| Q2 24 | 35.6% | 40.2% |
营业利润率AMRXUI
| Q1 26 | 19.6% | — | ||
| Q4 25 | 13.8% | 35.9% | ||
| Q3 25 | 9.0% | 35.7% | ||
| Q2 25 | 15.4% | 34.4% | ||
| Q1 25 | 14.4% | 34.2% | ||
| Q4 24 | 10.4% | 29.8% | ||
| Q3 24 | 12.6% | 30.7% | ||
| Q2 24 | 13.6% | 27.3% |
净利率AMRXUI
| Q1 26 | 10.8% | — | ||
| Q4 25 | 4.3% | 28.7% | ||
| Q3 25 | 0.3% | 28.3% | ||
| Q2 25 | 3.1% | 35.1% | ||
| Q1 25 | 1.8% | 27.2% | ||
| Q4 24 | -4.3% | 22.8% | ||
| Q3 24 | -0.0% | 23.3% | ||
| Q2 24 | 0.9% | 20.5% |
每股收益（稀释后）AMRXUI
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.10 | $3.86 | ||
| Q3 25 | $0.01 | $3.43 | ||
| Q2 25 | $0.07 | $4.40 | ||
| Q1 25 | $0.04 | $2.98 | ||
| Q4 24 | $-0.10 | $2.26 | ||
| Q3 24 | $0.00 | $2.12 | ||
| Q2 24 | $0.02 | $1.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $197.7M | $302.8M |
| 总债务越低越好 | — | $47.5M |
| 股东权益账面价值 | — | $1.0B |
| 总资产 | $3.5B | $1.6B |
| 负债/权益比越低杠杆越低 | — | 0.05× |
8季度趋势，按日历期对齐
现金及短期投资AMRXUI
| Q1 26 | $197.7M | — | ||
| Q4 25 | $282.0M | $302.8M | ||
| Q3 25 | $201.2M | $177.2M | ||
| Q2 25 | $71.5M | $149.7M | ||
| Q1 25 | $59.2M | $151.0M | ||
| Q4 24 | $110.6M | $133.1M | ||
| Q3 24 | $74.0M | $165.2M | ||
| Q2 24 | $43.8M | $126.3M |
总债务AMRXUI
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $47.5M | ||
| Q3 25 | $2.6B | $133.8M | ||
| Q2 25 | $2.2B | $250.0M | ||
| Q1 25 | $2.2B | $340.0M | ||
| Q4 24 | $2.4B | $406.3M | ||
| Q3 24 | $2.4B | $552.5M | ||
| Q2 24 | $2.4B | $708.1M |
股东权益AMRXUI
| Q1 26 | — | — | ||
| Q4 25 | $-70.8M | $1.0B | ||
| Q3 25 | $-109.5M | $828.4M | ||
| Q2 25 | $-112.1M | $668.3M | ||
| Q1 25 | $-131.7M | $436.1M | ||
| Q4 24 | $-109.3M | $290.4M | ||
| Q3 24 | $-93.4M | $188.1M | ||
| Q2 24 | $-57.5M | $95.1M |
总资产AMRXUI
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.7B | $1.6B | ||
| Q3 25 | $3.6B | $1.5B | ||
| Q2 25 | $3.4B | $1.5B | ||
| Q1 25 | $3.4B | $1.3B | ||
| Q4 24 | $3.5B | $1.2B | ||
| Q3 24 | $3.5B | $1.2B | ||
| Q2 24 | $3.5B | $1.2B |
负债/权益比AMRXUI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.37× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 2.94× | ||
| Q2 24 | — | 7.45× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $263.9M |
| 自由现金流经营现金流 - 资本支出 | — | $260.3M |
| 自由现金流率自由现金流/营收 | — | 31.9% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | — | 1.13× |
| 过去12个月自由现金流最近4个季度 | — | $699.5M |
8季度趋势，按日历期对齐
经营现金流AMRXUI
| Q1 26 | — | — | ||
| Q4 25 | $130.3M | $263.9M | ||
| Q3 25 | $118.5M | $198.5M | ||
| Q2 25 | $83.8M | $130.4M | ||
| Q1 25 | $7.4M | $123.6M | ||
| Q4 24 | $118.1M | $152.4M | ||
| Q3 24 | $141.8M | $233.7M | ||
| Q2 24 | $39.7M | $231.4M |
自由现金流AMRXUI
| Q1 26 | — | — | ||
| Q4 25 | $108.5M | $260.3M | ||
| Q3 25 | $106.2M | $193.3M | ||
| Q2 25 | $61.0M | $125.2M | ||
| Q1 25 | $-5.8M | $120.7M | ||
| Q4 24 | $102.9M | $150.4M | ||
| Q3 24 | $124.8M | $231.1M | ||
| Q2 24 | $29.0M | $229.5M |
自由现金流率AMRXUI
| Q1 26 | — | — | ||
| Q4 25 | 13.3% | 31.9% | ||
| Q3 25 | 13.5% | 26.3% | ||
| Q2 25 | 8.4% | 16.5% | ||
| Q1 25 | -0.8% | 18.2% | ||
| Q4 24 | 14.1% | 25.1% | ||
| Q3 24 | 17.8% | 42.0% | ||
| Q2 24 | 4.1% | 45.2% |
资本支出强度AMRXUI
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 0.4% | ||
| Q3 25 | 1.6% | 0.7% | ||
| Q2 25 | 3.2% | 0.7% | ||
| Q1 25 | 1.9% | 0.4% | ||
| Q4 24 | 2.1% | 0.3% | ||
| Q3 24 | 2.4% | 0.5% | ||
| Q2 24 | 1.5% | 0.4% |
现金转化率AMRXUI
| Q1 26 | — | — | ||
| Q4 25 | 3.72× | 1.13× | ||
| Q3 25 | 50.00× | 0.95× | ||
| Q2 25 | 3.74× | 0.49× | ||
| Q1 25 | 0.61× | 0.68× | ||
| Q4 24 | — | 1.11× | ||
| Q3 24 | — | 1.83× | ||
| Q2 24 | 6.62× | 2.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRX
暂无分部数据
UI
| Enterprise Technology | $729.0M | 89% |
| Service Provider Technology | $85.9M | 11% |
